Dog Mammary Tumor Study Finds Limited Urine Signals

In an observational case-control study of 118 female dogs (71 with mammary tumors, 47 controls), urinary metabolomics showed limited, preliminary associations mainly tied to tumor size after statistical adjustment.

Journal: Frontiers in Veterinary Science
Sample Size: 118
Study Type: Original metabolomics research
Published: 2026-07-14
Species:

Key Findings

  • After adjustment for diet and other covariates, the overall case-control and tumor-number comparisons did not retain significant urinary features.
  • The clearest remaining pattern was by tumor size; hippurate was lower in the six dogs with large tumors.
  • Only four urinary features differed between malignant and benign tumors, making findings preliminary and non-diagnostic.

Dog Mammary Tumor Urine Research: Early and Limited Findings

A urine metabolomics study in dogs with mammary tumors offers early clues, but it does not show that urine can diagnose cancer in clinic right now. In Frontiers in Veterinary Science, researchers ran an observational case-control study of 118 female dogs: 71 with mammary tumors and 47 tumor-free controls. After adjusting for diet and other covariates, broad urine-pattern differences did not hold up. The remaining signals were limited and mostly related to tumor size.

Mammary tumors are one of the most common tumors seen in female dogs, especially those that were not spayed early in life. Getting a clear picture of how serious a tumor is currently requires imaging, tissue biopsies, and pathology testing — all of which can be stressful and costly. The idea of gathering useful information from urine, which is easy and painless to collect, is an exciting prospect for dog owners and veterinarians alike.

Why Researchers Looked at Urine Metabolites

To understand why this research matters, it helps to know a little about metabolites — the tiny chemical by-products your dog’s body constantly produces as it goes about its business. Think of metabolites as the exhaust fumes of your dog’s inner chemistry. When something unusual is happening in the body — like the growth of a tumor — those chemical by-products can shift in noticeable ways.

The field that studies these chemical patterns is called metabolomics — essentially, reading the body’s chemistry like a storybook. Scientists have used metabolomics in human medicine for years to look for cancer signals in blood, urine, and other fluids. This study explored whether the same approach could work in dogs with mammary tumors.

Until now, there has been limited research on whether urine chemistry could reflect what is happening inside a canine mammary tumor. This study took an important step toward filling that gap.

How the Study Was Done

The team analyzed urine from 118 female dogs:

  • 71 dogs with mammary tumors (cases)
  • 47 dogs without known mammary tumors (controls)

They compared urinary metabolite profiles across:

  • case vs. control groups
  • tumor number
  • tumor size (including small groups of 12 medium and 6 large tumors)
  • benign vs. malignant tumors

Because this was observational research, it can show associations, not proof that a tumor directly caused a urine pattern.

What the Researchers Found

No Adjusted Overall Case-Control or Tumor-Number Signal

Some differences appeared in simpler comparisons, but after adjustment for diet and other covariates, the overall case-control comparison and tumor-number analysis did not retain significant urinary features.

The Strongest Remaining Signal Was Linked to Tumor Size

The clearest remaining signature was primarily tied to tumor size, and one notable finding was that hippurate was lower in the six dogs with large tumors.

Malignant vs. Benign: Only Four Features Differed

Only four urinary features differed between malignant and benign tumor groups. That small signal supports more research, but it is not enough to treat urine metabolomics as a stand-alone diagnostic method.

What This Means for Dog Owners

Useful for Research, Not a Clinical Test

This work is preliminary. It does not mean a urine test can currently tell whether a mammary tumor is cancerous, measure severity, or replace standard diagnostic care.

Future research will need to confirm these findings in larger groups of dogs, identify exactly which metabolites are the most reliable indicators, and eventually develop a practical test that vets can use in everyday practice.

What You Can Do Right Now

If your female dog has a mammary lump or has been diagnosed with a mammary tumor, here is what matters most today:

  • Don’t wait to see a vet. Any new lump on your dog’s chest or belly area deserves prompt professional evaluation.
  • Ask about the full diagnostic picture. Your vet may recommend imaging, sampling, surgery, and tissue analysis.
  • Know the diagnostic standard. Histopathology (microscopic review of tumor tissue) remains the standard for confirming benign vs. malignant status.
  • Consider spaying. Spaying before a dog’s first heat cycle greatly reduces the risk of mammary tumors later in life. Talk to your vet about the right timing for your dog.

When to Contact Your Veterinarian

Reach out to your vet if you notice any of the following in your female dog:

  • A lump or swelling along the mammary glands (the row of nipples on the belly)
  • A lump that is growing, feels hard, or is attached to the skin
  • Discharge from a nipple
  • Signs of pain or discomfort in the belly area

Catching mammary tumors early — when they are still small — gives your dog the best chance of a good outcome.

Study Limitations to Keep in Mind

The findings should be interpreted cautiously:

  • Even with 118 dogs overall, some key subgroups were small (12 medium-tumor dogs and 6 large-tumor dogs).
  • Baseline differences between groups and incomplete covariate overlap can make comparisons harder to interpret.
  • Control dogs were screened using palpation and owner history, not definitive exclusion methods for occult disease.
  • This was an observational case-control design, so it cannot prove cause and effect.
  • Many initial findings were substantially reduced after adjustment for diet and other covariates, showing sensitivity to confounding factors.

The Bottom Line

This study suggests limited, preliminary urine-metabolite associations in dogs with mammary tumors, with the strongest signal linked to tumor size and lower hippurate in six large-tumor dogs. After adjustment, broad overall and tumor-number signals did not remain significant, and only four features separated malignant from benign groups. Urine metabolomics is research-stage only, while veterinarian-led diagnostics and histopathology remain the clinical standard.

For now, the best thing any dog owner can do is stay alert to changes in their dog’s body, schedule regular vet checkups, and seek prompt evaluation for any new lumps or bumps.


This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.

Reference

Urinary metabolite profiles differ by tumor size and malignancy in dogs with mammary tumors. (2026). Frontiers in Veterinary Science. DOI: https://doi.org/10.3389/fvets.2026.1834546